LNSR

LENSAR Inc

Jun 12 • 04:00PM ET

5.82

0.00 0.00 %

Healthcare • Medical Devices • USA • Micro • NASD

Peers: POAS BDMD SERA RXST SGHT TLSI INGN LUCD MASS SENS

| Held by: VTI IWM VXF IWO VTWO IWC DFMC DFAS GSSC VTWG

Index	RUT	P/E	-	EPS (ttm)	-0.57	Insider Own	24.54%	Shs Outstand	12.10M	Perf Week	3.93%
Market Cap	70.45M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	0.00%	Shs Float	9.13M	Perf Month	0.87%
Enterprise Value	73.31M	PEG	-	EPS next Q	-0.17	Inst Own	52.01%	Short Float	9.55%	Perf Quarter	-40.91%
Income	11.98M	P/S	1.22	EPS this Y	127.35%	Inst Trans	4.25%	Short Ratio	7.33	Perf Half Y	-49.61%
Sales	57.70M	P/B	6.53	EPS next Y	-144.59%	ROA	17.21%	Short Interest	0.87M	Perf YTD	-49.96%
Book/sh	0.89	P/C	5.22	EPS next 5Y	-	ROE	147.73%	52W High	13.47 -56.79%	Perf Year	-53.44%
Cash/sh	1.11	P/FCF	-	EPS past 3/5Y	-13.51% -9.65%	ROIC	45.44%	52W Low	5.06 15.02%	Perf 3Y	34.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	18.23% 17.24%	Gross Margin	44.12%	Volatility	3.00% 4.11%	Perf 5Y	-32.01%
Dividend TTM	-	EV/Sales	1.27	EPS Y/Y TTM	120.17%	Oper. Margin	-28.68%	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.08	Sales Y/Y TTM	1.12%	Profit Margin	20.76%	RSI (14)	51.13	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.38	EPS Q/Q	100.10%	SMA20	0.71%	Beta	0.86	Target Price	8.50
Payout	-	Debt/Eq	0.10	Sales Q/Q	-5.16%	SMA50	2.53%	Rel Volume	0.24	Prev Close	5.82
Employees	150	LT Debt/Eq	0.07	Earnings	May 08 BMO	SMA200	-41.15%	Avg Volume	118.95K	Price	5.82
IPO	Oct 02, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-100.00% -6.03%	Trades		Volume	27,980	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-01-26	Upgrade	Lake Street	Hold → Buy	$10
Mar-18-26	Upgrade	BTIG Research	Neutral → Buy	$10
Feb-24-21	Initiated	SVB Leerink	Outperform	$20

May-08-26 07:00AM	LENSAR Reports First Quarter 2026 Results and Provides Business Update (GlobeNewswire) +7.84%
Apr-30-26 07:00AM	LENSAR to Report First Quarter 2026 Results on May 8, 2026 (GlobeNewswire)
Apr-03-26 09:00PM	LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Apr-01-26 08:30AM	LENSAR, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-31-26 06:00AM	LENSAR Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update (GlobeNewswire)
09:18AM	Loading…
Mar-30-26 09:18AM	Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2025 Result (GuruFocus.com)
Mar-17-26 09:33AM	BYND And LNSR Set The Tone Tuesday (GuruFocus.com) -32.85%
06:57AM	Alcon abandons effort to purchase LENSAR after FTC scrutiny (MedTech Dive)
Mar-16-26 04:57PM	Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement (Business Wire)
04:30PM	LENSAR Announces Termination of Merger Agreement with Alcon Research, LLC (GlobeNewswire)
Feb-25-26 05:00PM	LENSAR Provides Update on Pending Acquisition by Alcon (GlobeNewswire)
Nov-06-25 07:00AM	LENSAR Reports Third Quarter 2025 Results and Provides Business Update (GlobeNewswire) -8.63%
Sep-02-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-07-25 07:00AM	LENSAR Reports Second Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Jul-01-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
04:01PM	Loading…
Jun-02-25 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-08-25 07:00AM	LENSAR Reports First Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Apr-24-25 09:20AM	LENSAR: It Is All About The Contingent Value Right Now (Seeking Alpha)
Apr-10-25 01:59PM	Alcon: A Clear Vision, But Fully Valued (Seeking Alpha)
08:35AM	Is LENSAR (LNSR) a Deeply Undervalued Stock? (Insider Monkey)
Mar-25-25 09:00AM	Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit (TipRanks)
08:35AM	ALC Stock Rises Following the Merger Agreement With LENSAR (Zacks)
Mar-24-25 08:00AM	Alcon Agrees to Acquire LENSAR, Inc. (GlobeNewswire)
Mar-03-25 07:03PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-28-25 02:17AM	LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com) +19.60%
Feb-27-25 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update (GlobeNewswire) +14.78%
Feb-26-25 08:18AM	Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2024 Result (GuruFocus.com)
Feb-19-25 12:00PM	LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 (GlobeNewswire)
Feb-03-25 07:33PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.63%
Jan-02-25 06:08PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
04:01PM	Loading…
Dec-09-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-26-24 08:00AM	LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day (GlobeNewswire)
Nov-08-24 02:14AM	LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion (GuruFocus.com) +7.42%
Nov-07-24 07:00AM	LENSAR Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +17.24%
Nov-06-24 07:53AM	LENSAR Inc (LNSR) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-01-24 06:32PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.28% +8.92%
Oct-31-24 07:00AM	LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:15AM	Lensar announces more than 1M procedures completed with cataract laser systems (TipRanks)
Oct-08-24 08:00AM	One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems (GlobeNewswire) +6.11%
Oct-01-24 06:25PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-04-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-08-24 07:00AM	LENSAR Reports Second Quarter 2024 Results and Provides Business Update (Business Wire) -9.93%
Aug-07-24 07:00AM	LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union (Business Wire) -7.90%
Aug-01-24 06:42PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:00AM	LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (Business Wire)
Jul-05-24 10:00AM	3 Under-$10 Stocks With the Potential to Make You a Millionaire (InvestorPlace)
Jul-02-24 05:50PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.80%
Jun-03-24 06:34PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.33%
May-23-24 08:00AM	LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-13-24 11:14AM	LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 11:57AM	LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.68%
07:00AM	LENSAR Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 08:00AM	LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (Business Wire)
May-01-24 06:38PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-01-24 06:28PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-05-24 09:11AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.97%
Mar-04-24 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (Business Wire)
Mar-01-24 05:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-24 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 (Business Wire)
Nov-12-23 09:38AM	LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 07:00AM	LENSAR Reports Third Quarter 2023 Results and Provides Business Update (Business Wire) +12.44%
Nov-02-23 08:03AM	LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (Business Wire) +5.12%
Aug-09-23 07:00AM	LENSAR Reports Second Quarter 2023 Results and Provides Business Update (Business Wire) +12.73%
Jul-24-23 07:00AM	LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups (Business Wire)
May-15-23 07:00AM	LENSAR Reports First Quarter 2023 Results and Provides Business Update (Business Wire) -9.45%
May-10-23 08:00AM	LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (Business Wire)
Mar-20-23 03:05AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.98%
Mar-16-23 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update (Business Wire)
Mar-09-23 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 (Business Wire)
Feb-14-23 07:00AM	LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results (Business Wire)
Nov-22-22 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-09-22 07:00AM	LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -11.56%
Nov-02-22 08:00AM	LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 (Business Wire)
Sep-08-22 07:00AM	LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU (Business Wire)
Aug-16-22 07:00AM	First Patients Treated with LENSARs® ALLY Adaptive Cataract Treatment System (Business Wire)
Aug-08-22 07:00AM	LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-01-22 08:00AM	LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022 (Business Wire)
Jun-13-22 07:00AM	LENSAR® Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System (Business Wire)
Jun-09-22 07:30AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
May-09-22 07:00AM	LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-02-22 08:00AM	LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (Business Wire)
Apr-21-22 09:08AM	We're Not Very Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Rate (Simply Wall St.)
Mar-03-22 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +6.34%
Mar-01-22 07:00AM	LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY (Business Wire)
Feb-28-22 04:01PM	LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022 (Business Wire)
Feb-23-22 02:01AM	Should Now Consider Selling Your LENSAR (LNSR) Shares? (Insider Monkey)
Feb-10-22 08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Jan-04-22 08:00AM	LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference (Business Wire)
Dec-31-21 07:53AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
Nov-16-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-12-21 07:00AM	LENSAR Announces Poster Presentations at the American Academy of Ophthalmology (Business Wire)
Nov-08-21 07:00AM	LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Nov-01-21 08:00AM	LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021 (Business Wire)
Oct-02-21 10:32AM	We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-02-21 08:00AM	LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (Business Wire)
Aug-16-21 08:00AM	LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference (Business Wire)
Aug-05-21 07:00AM	LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Jul-29-21 08:00AM	LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 (Business Wire)
Jul-15-21 08:00AM	LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting (Business Wire)

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

PresidentMr. Nicholas T. Curtis

Chief Operating OfficerMr. Alan B. Connaughton

Interim CFO & Principal Financial OfficerMr. Michael A. Rossi

Principal Accounting OfficerMs. Kendra W. Wong

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STAAB THOMAS R II	Officer	May 12 '26	Proposed Sale	5.75	850	4,888		May 12 01:12 PM
STAAB THOMAS R II	Chief Financial Officer	Mar 19 '26	Option Exercise	2.65	5,500	14,575	175,959	Mar 19 04:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LNSR

LENSAR Inc

Upgrade your Finviz experience